Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Caffeine and Rosuvastatin in Ischemia-Reperfusion Injury
NCT00457652Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jun 2007
- Primary completion
- Sep 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of rosuvastatin in ischemia-reperfusion injury (IRI), sponsored by Radboud University Medical Center. Started Jun 2007; status: completed.
02
Drugs
rosuvastatin
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT00457652.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00457652.